Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients
We retrospectively analysed the results of patients with advanced non-small-cell lung cancer treated with gefitinib to derive clinical factors predictive of response and a favourable survival outcome. Patients were treated with gefitinib 250 mg per day and re-evaluated 4–8 weeks later with repeat CT...
Saved in:
Published in | British journal of cancer Vol. 93; no. 1; pp. 23 - 28 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
11.07.2005
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We retrospectively analysed the results of patients with advanced non-small-cell lung cancer treated with gefitinib to derive clinical factors predictive of response and a favourable survival outcome. Patients were treated with gefitinib 250 mg per day and re-evaluated 4–8 weeks later with repeat CT scan and every 8 weeks thereafter to assess response and the duration of response. Pathology review by a histopathologist was conducted, in particular to confirm a recently published result of bronchioloalveolar carcinoma histology or its components as predictive of response to gefitinib. Logistic regression and Cox regression analytical methods were applied to determine factors that could predict for response and improved overall survival. A total of 110 patients were treated. The overall response rate was 32% partial responses (PRs). Only never-smoking status was predictive of response in the logistic regression analysis, adjusted OR=6.1, 95% CI=1.7, 21.5. The presence of a PR and good performance status were predictive of a favourable survival outcome from the Cox regression modelling. Responders had an adjusted HR of 3.0, 95% CI=1.5–5.8 compared to nonresponders, while patients with ECOG status 0–1 had an adjusted HR of 0.42, 95% CI=0.25–0.72, compared with patients with ECOG status 2–4. Bronchioloalveolar carcinoma or its components were distinctly absent on pathology review. In conclusions, Never-smoking status is an important clinical predictor of a favourable response to gefitinib. |
---|---|
AbstractList | We retrospectively analysed the results of patients with advanced non-small-cell lung cancer treated with gefitinib to derive clinical factors predictive of response and a favourable survival outcome. Patients were treated with gefitinib 250 mg per day and re-evaluated 4–8 weeks later with repeat CT scan and every 8 weeks thereafter to assess response and the duration of response. Pathology review by a histopathologist was conducted, in particular to confirm a recently published result of bronchioloalveolar carcinoma histology or its components as predictive of response to gefitinib. Logistic regression and Cox regression analytical methods were applied to determine factors that could predict for response and improved overall survival. A total of 110 patients were treated. The overall response rate was 32% partial responses (PRs). Only never-smoking status was predictive of response in the logistic regression analysis, adjusted OR=6.1, 95% CI=1.7, 21.5. The presence of a PR and good performance status were predictive of a favourable survival outcome from the Cox regression modelling. Responders had an adjusted HR of 3.0, 95% CI=1.5–5.8 compared to nonresponders, while patients with ECOG status 0–1 had an adjusted HR of 0.42, 95% CI=0.25–0.72, compared with patients with ECOG status 2–4. Bronchioloalveolar carcinoma or its components were distinctly absent on pathology review. In conclusions, Never-smoking status is an important clinical predictor of a favourable response to gefitinib. |
Author | Chuah, K-L Tan, E-H Lim, S-T Lim, W-T Leong, S-S Toh, C-K Wong, E-H Tay, M-H |
Author_xml | – sequence: 1 givenname: S-T surname: Lim fullname: Lim, S-T organization: Department of Medical Oncology, National Cancer Centre – sequence: 2 givenname: E-H surname: Wong fullname: Wong, E-H organization: Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre – sequence: 3 givenname: K-L surname: Chuah fullname: Chuah, K-L organization: Department of Pathology, Singapore General Hospital – sequence: 4 givenname: S-S surname: Leong fullname: Leong, S-S organization: Department of Medical Oncology, National Cancer Centre – sequence: 5 givenname: W-T surname: Lim fullname: Lim, W-T organization: Department of Medical Oncology, National Cancer Centre – sequence: 6 givenname: M-H surname: Tay fullname: Tay, M-H organization: Department of Medical Oncology, National Cancer Centre – sequence: 7 givenname: C-K surname: Toh fullname: Toh, C-K organization: Department of Medical Oncology, National Cancer Centre – sequence: 8 givenname: E-H surname: Tan fullname: Tan, E-H email: dmoteh@nccs.com.sg organization: Department of Medical Oncology, National Cancer Centre, Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16951966$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15942627$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1v1DAQhi1URLeFKzeQhQS3bG3HH3EPSFUFBakSFzhbjjvZOiT2YicL_Hu82tAFJE7WzPvMzDueM3QSYgCEnlOypqRuLnK_bnu3lpIwKdgjtKKiZhVtmDpBK0KIqohm5BSd5dyXUJNGPUGnVGjOJFMrNN5A5ycffIt9xmNMgKHrwE1-B9gHHGAHqcpj_Aop4-9-usfFQUnYYagcDAMe5rDBzgYH6RLDjy0kDyXAdoxFuMreBry1U0lO-Sl63Nkhw7PlPUdf3r_7fP2huv108_H66rZygqipqrltheSEUyp5w7pWWct0R1RnBZfKtVQIDkq2nEhWa24bWjtHWwZ3WjJH6nP09tB3O7cj3LkyO9nBbJMfbfppovXmbyX4e7OJO8NqSbmmpcGbpUGK32bIkxl93q9rA8Q5G9kQwmqlCvjqH7CPcwplOcOY1o3WZG9nfYBcijkn6B6cUGL2ZzS5N-WMZjljKXj5p_8jvtytAK8XwGZnhy6V__f5yEktqJaycBcHLhcpbCAd7f139ItDRbDTnOCh5W_9FwNPwq0 |
CODEN | BJCAAI |
CitedBy_id | crossref_primary_10_1016_j_lungcan_2005_12_015 crossref_primary_10_1016_j_mehy_2012_09_003 crossref_primary_10_5301_JBM_5000039 crossref_primary_10_1111_j_1349_7006_2007_00688_x crossref_primary_10_1007_s10147_006_0583_4 crossref_primary_10_1158_1078_0432_CCR_09_0377 crossref_primary_10_1200_JCO_2014_58_1736 crossref_primary_10_1038_nrc2190 crossref_primary_10_1111_j_1440_1843_2006_00954_x crossref_primary_10_1002_cncr_22220 crossref_primary_10_1097_01243894_200607000_00004 crossref_primary_10_1038_sj_bjc_6603710 crossref_primary_10_1159_000371735 crossref_primary_10_1111_j_1440_1843_2006_00840_x crossref_primary_10_47102_annals_acadmedsg_V46N9p333 crossref_primary_10_1111_1759_7714_12989 crossref_primary_10_1200_JCO_2011_36_8456 crossref_primary_10_2482_haigan_49_409 crossref_primary_10_2217_fon_2021_0934 crossref_primary_10_1016_S0169_5002_08_70102_8 crossref_primary_10_1016_S1556_0864_15_30353_1 crossref_primary_10_1038_nrd2360 |
Cites_doi | 10.1126/science.1099314 10.1200/JCO.2003.10.038 10.1200/JCO.2004.08.001 10.1056/NEJM200103153441101 10.1016/S0003-4975(02)03897-3 10.1200/JCO.2005.01.388 10.1056/NEJMoa040938 10.1378/chest.126.6.1750 10.1200/JCO.2004.07.215 10.1200/JCO.2004.08.158 10.1001/jama.290.16.2149 10.1136/bmj.311.7010.899 10.1200/jco.2004.22.14_suppl.7061 10.1002/ijc.2910350202 10.1002/ijc.2910200606 10.1002/ijc.2910400505 10.1093/annonc/mdh177 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A 10.1200/JCO.2000.18.10.2095 10.1056/NEJMoa020461 |
ContentType | Journal Article |
Copyright | The Author(s) 2005 2005 INIST-CNRS Copyright Nature Publishing Group Jul 11, 2005 Copyright © 2005 Cancer Research UK 2005 Cancer Research UK |
Copyright_xml | – notice: The Author(s) 2005 – notice: 2005 INIST-CNRS – notice: Copyright Nature Publishing Group Jul 11, 2005 – notice: Copyright © 2005 Cancer Research UK 2005 Cancer Research UK |
DBID | C6C IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7TO 7U9 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1038/sj.bjc.6602652 |
DatabaseName | SpringerOpen Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (Proquest) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central British Nursing Database ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Favourable response to gefitinib in NSCLC patients |
EISSN | 1532-1827 |
EndPage | 28 |
ExternalDocumentID | 971722361 10_1038_sj_bjc_6602652 15942627 16951966 6602652 |
Genre | Journal Article |
GroupedDBID | - -Q- 02 0R 23N 39C 3V. 4.4 53G 55 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AADWK AAPBV AAWBL AAWTL AAYJO AAZLF ABAWZ ABDBF ABDEU ABFLS ABGIJ ABOCM ABPTK ABUWG ACGFS ACKTT ACPRK ADACO ADBBV ADHDB ADQMX AEDAW AEJRE AENEX AFKRA AFRAH AFSHS AGEZK AHMBA AHSBF AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AN0 ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBAFP BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI CAG COF CS3 DIK DU5 E3Z EAD EAP EAS EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EPL ESX EX3 F5P FDQFY FEDTE FERAY FIZPM FRJ FSGXE FYUFA GX1 HCIFZ HVGLF HYE HZ IH2 J5H JSO KQ8 M1P M7P NAO NAPCQ O9- OK1 P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q- Q2X RIG RNT RNTTT RPM SNX SNYQT SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UDS VH1 W2D WH7 WOW X7M XFK ZA5 --- .55 0R~ 36B 406 6J9 AANZL AAYZH ABAKF ABLJU ABZZP ACAOD ACGFO ACRQY ACZOJ ADFRT AEFQL AEMSY AEVLU AFBBN AGAYW AGHAI AGQEE AI. AMYLF AOIJS C6C CCPQU DNIVK DPUIP EMOBN HMCUK HZ~ IWAJR JZLTJ NQJWS SOHCF SRMVM UKHRP ~02 ~8M .GJ 08R 70F 8WZ A6W AATNV AAUGY AAYFA ACBMV ACBRV ACBYP ACIGE ACTTH ACVWB ADMDM ADYYL AEFTE AEXYK AFNRJ AGGBP AILAN AJCLW AJDOV AMRJV IQODW M41 NYICJ Y6R ZGI CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TO 7U9 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 7X8 5PM |
ID | FETCH-LOGICAL-c507t-34ab56404116482fb7aa29f07fa5467cb1554e76b4062394a813cc1b2ed962c03 |
IEDL.DBID | RPM |
ISSN | 0007-0920 |
IngestDate | Tue Sep 17 21:13:05 EDT 2024 Fri Oct 25 01:59:54 EDT 2024 Wed Nov 06 09:00:24 EST 2024 Fri Dec 06 06:26:01 EST 2024 Wed Oct 16 00:42:36 EDT 2024 Sun Oct 22 16:06:40 EDT 2023 Thu Dec 12 04:11:04 EST 2024 Thu Oct 07 19:33:37 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | never-smoker gefitinib non-small-cell lung cancer Antineoplastic agent Human Lung disease Asiatic Respiratory disease Enzyme Transferases Lung cancer Enzyme inhibitor Malignant tumor non-small cell lung carcinoma Epidermal growth factor receptor Non smoker Cancerology Efficiency Smoker Bronchus disease Gefitinib Protein-tyrosine kinase |
Language | English |
License | CC BY 4.0 http://www.springer.com/tdm This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c507t-34ab56404116482fb7aa29f07fa5467cb1554e76b4062394a813cc1b2ed962c03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361491/ |
PMID | 15942627 |
PQID | 229989900 |
PQPubID | 41855 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2361491 proquest_miscellaneous_68002377 proquest_journals_229989900 crossref_primary_10_1038_sj_bjc_6602652 pubmed_primary_15942627 pascalfrancis_primary_16951966 springer_journals_10_1038_sj_bjc_6602652 nature_primary_6602652 |
ProviderPackageCode | ABDEU AEDAW AAZLF -Q- AADWK AAYJO ADQMX EE. RNTTT SWTZT ABGIJ RNT NAO |
PublicationCentury | 2000 |
PublicationDate | 2005-07-11 |
PublicationDateYYYYMMDD | 2005-07-11 |
PublicationDate_xml | – month: 07 year: 2005 text: 2005-07-11 day: 11 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
PublicationTitle | British journal of cancer |
PublicationTitleAbbrev | Br J Cancer |
PublicationTitleAlternate | Br J Cancer |
PublicationYear | 2005 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – sequence: 0 name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Fukuoka, M, Yano, S, Giaccone, G, Tamura, T, Nakagawa, K, Douillard, JY, Nishiwaki, Y, Vansteenkiste, J, Kudoh, S, Rischin, D, Eek, R, Horai, T, Noda, K, Takata, I, Smit, E, Averbuch, S, Macleod, A, Feyereislova, A, Dong, RP, Baselga, J 2003; 21 Ebright, MI, Zakowski, MF, Martin, J, Venkatraman, ES, Miller, VA, Bains, MS, Downey, RJ, Korst, RJ, Kris, MG, Rusch, VW 2002; 74 Haringhuizen, A, van Tinteren, H, Vaessen, HF, Baas, P, van Zandwijk, N 2004; 15 Lynch, TJ, Bell, DW, Sordella, R, Gurubhagavatula, S, Okimoto, RA, Brannigan, BW, Harris, PL, Haserlat, SM, Supko, JG, Haluska, FG, Louis, DN, Christiani, DC, Settleman, J, Haber, DA 2004; 350 Ahrendt, SA, Chow, JT, Yang, SC, Wu, L, Zhang, MJ, Jen, J, Sidransky, D 2000; 60 Bunn, PA 2002; 20 Han, SW, Kim, TY, Hwang, PG, Jeong, S, Kim, J, Choi, IS, Oh, DY, Kim, JH, Kim, DW, Chung, DH, Im, SA, Kim, YT, Lee, JS, Heo, DS, Bang, YJ, Kim, NK 2005; 23 1995; 311 Wong, MP, Lam, WK, Wang, E, Chiu, SW, Lam, CL, Chung, LP 2002; 62 Paez, JG, Janne, PA, Lee, JC, Tracy, S, Greulich, H, Gabriel, S, Herman, P, Kaye, FJ, Lindeman, N, Boggon, TJ, Naoki, K, Sasaki, H, Fujii, Y, Eck, MJ, Sellers, WR, Johnson, BE, Meyerson, M 2004; 304 Demetri, GD, von Mehren, M, Blanke, CD, Van den Abbeele, AD, Eisenberg, B, Roberts, PJ, Heinrich, MC, Tuveson, DA, Singer, S, Janicek, M, Fletcher, JA, Silverman, SG, Silberman, SL, Capdeville, R, Kiese, B, Peng, B, Dimitrijevic, S, Druker, BJ, Corless, C, Fletcher, CD, Joensuu, H 2002; 347 Herbst, RS, Giaccone, G, Schiller, JH, Natale, RB, Miller, V, Manegold, C, Scagliotti, G, Rosell, R, Oliff, I, Reeves, JA, Wolf, MK, Krebs, AD, Averbuch, SD, Ochs, JS, Grous, J, Fandi, A, Johnson, DH 2004; 22 Miller, VA, Herbst, RS, Prager, D 2004a; 22 Kris, MG, Natale, RB, Herbst, RS, Lynch, TJ, Prager, D, Belani, CP, Schiller, JH, Kelly, K, Spiridonidis, H, Sandler, A, Albain, KS, Cella, D, Wolf, MK, Averbuch, SD, Ochs, JJ, Kay, AC 2003; 290 Toh, CK, Wong, EH, Lim, WT, Leong, SS, Fong, KW, Wee, J, Tan, EH 2004; 126 Gealy, R, Zhang, L, Siegfried, JM, Luketich, JD, Keohavong, P 2001; 8 Bailey, LR, Kris, M, Wolf, M 2003; 44 Shepherd, FA, Dancey, J, Ramlau, R, Mattson, K, Gralla, R, O'Rourke, M, Levitan, N, Gressot, L, Vincent, M, Burkes, R, Coughlin, S, Kim, Y, Berille, J 2000; 18 Gao, YT, Blot, WJ, Zheng, W, Ershow, AG, Hsu, CW, Levin, LI, Zhang, R, Fraumeni, JF 1987; 40 Yu, D, Hung, MC 2000; 22 Giaccone, G, Herbst, RS, Manegold, C, Scagliotti, G, Rosell, R, Miller, V, Natale, RB, Schiller, JH, Von Pawel, J, Pluzanska, A, Gatzemeier, U, Grous, J, Ochs, JS, Averbuch, SD, Wolf, MK, Rennie, P, Fandi, A, Johnson, DH 2004; 22 Sanchez-Cespedes, M, Ahrendt, SA, Piantadosi, S, Rosell, R, Monzo, M, Wu, L, Westra, WH, Yang, SC, Jen, J, Sidransky, D 2001; 61 MacLennan, R, Da Costa, J, Day, NE, Law, CH, Ng, YK, Shanmugaratnam, K 1977; 20 Han, SW, Kim, TY, Hwang, PG, Jeong, S, Kim, J, Choi, IS, Oh, DY, Kim, JH, Kim, DW, Chung, DH, Im, SA, Kim, YT, Lee, JS, Heo, DS, Bang, YJ, Kim, NK 1990; 10 Koo, LC, Ho, JH, Lee, N 1985; 35 Slamon, DJ, Leyland-Jones, B, Shak, S, Fuchs, H, Paton, V, Bajamonde, A, Fleming, T, Eiermann, W, Wolter, J, Pegram, M, Baselga, J, Norton, L 2001; 344 Miller, VA, Kris, MG, Shah, N, Patel, J, Azzoli, C, Gomez, J, Krug, LM, Pao, W, Rizvi, N, Pizzo, B, Tyson, L, Venkatraman, E, Ben-Porat, L, Memoli, N, Zakowski, M, Rusch, V, Heelan, RT 2004b; 22 GD Demetri (BF6602652_CR4) 2002; 347 SA Ahrendt (BF6602652_CR1) 2000; 60 D Yu (BF6602652_CR27) 2000; 22 MG Kris (BF6602652_CR15) 2003; 290 LR Bailey (BF6602652_CR2) 2003; 44 SW Han (BF6602652_CR11) 1990; 10 LC Koo (BF6602652_CR14) 1985; 35 R Gealy (BF6602652_CR8) 2001; 8 RS Herbst (BF6602652_CR13) 2004; 22 A Haringhuizen (BF6602652_CR12) 2004; 15 VA Miller (BF6602652_CR18) 2004; 22 SW Han (BF6602652_CR10) 2005; 23 R MacLennan (BF6602652_CR17) 1977; 20 PA Bunn Jr (BF6602652_CR3) 2002; 20 YT Gao (BF6602652_CR7) 1987; 40 TJ Lynch (BF6602652_CR16) 2004; 350 G Giaccone (BF6602652_CR9) 2004; 22 DJ Slamon (BF6602652_CR24) 2001; 344 JG Paez (BF6602652_CR21) 2004; 304 CK Toh (BF6602652_CR25) 2004; 126 BF6602652_CR20 M Sanchez-Cespedes (BF6602652_CR22) 2001; 61 VA Miller (BF6602652_CR19) 2004; 22 MP Wong (BF6602652_CR26) 2002; 62 FA Shepherd (BF6602652_CR23) 2000; 18 M Fukuoka (BF6602652_CR6) 2003; 21 MI Ebright (BF6602652_CR5) 2002; 74 |
References_xml | – volume: 344 start-page: 783 year: 2001 end-page: 792 article-title: Use of chemotherapy plus a monoclonal antibody against HER 2 for metastatic breast cancer that overexpresses HER 2 publication-title: N Engl J Med contributor: fullname: Norton, L – volume: 350 start-page: 2129 year: 2004 end-page: 2139 article-title: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib publication-title: N Engl J Med contributor: fullname: Haber, DA – volume: 44 start-page: 1362 year: 2003 article-title: Tumor EGFR membrane staining is not clinically relevant for predicting response in patients receiving gefitinib ('Iressa', ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer: IDEAL 1 and 2 publication-title: Proc Am Assoc Cancer Res contributor: fullname: Wolf, M – volume: 22 start-page: 777 year: 2004 end-page: 784 article-title: A phase III clinical trial of Gefitinib, an EGFR inhibitor, in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer (INTACT 1) publication-title: J Clin Oncol contributor: fullname: Johnson, DH – volume: 290 start-page: 2149 year: 2003 end-page: 2158 article-title: Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial publication-title: JAMA contributor: fullname: Kay, AC – volume: 21 start-page: 2237 year: 2003 end-page: 2246 article-title: A multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer (The IDEAL 1 Trial) publication-title: J Clin Oncol contributor: fullname: Baselga, J – volume: 62 start-page: 4464 year: 2002 end-page: 4468 article-title: Primary adenocarcinoma of the lung in nonsmokers show a distinct pattern of allelic imbalance publication-title: Cancer Res contributor: fullname: Chung, LP – volume: 8 start-page: 297 year: 2001 end-page: 302 article-title: Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women publication-title: Cancer Epidemiol Biomarkers Prev contributor: fullname: Keohavong, P – volume: 15 start-page: 786 year: 2004 end-page: 792 article-title: Gefitinib as a last treatment option for non-small cell lung cancer: durable disease control in a subset of patients publication-title: Ann Oncol contributor: fullname: van Zandwijk, N – volume: 22 start-page: 7061 year: 2004a article-title: Long survival of never smoking non-small cell lung cancer patients treated with erlotinib HCl (OSI-774) and chemotherapy: subgroup analysis of TRIBUTE publication-title: J Clin Oncol contributor: fullname: Prager, D – volume: 23 start-page: 2493 year: 2005 end-page: 2501 article-title: Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib publication-title: J Clin Oncol contributor: fullname: Kim, NK – volume: 311 start-page: 899 year: 1995 end-page: 909 article-title: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials publication-title: BMJ – volume: 10 start-page: 971 year: 1990 end-page: 976 article-title: Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan publication-title: Anticancer Res contributor: fullname: Kim, NK – volume: 18 start-page: 2095 year: 2000 end-page: 2103 article-title: Prospective randomized trial of docetaxel best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy publication-title: J Clin Oncol contributor: fullname: Berille, J – volume: 40 start-page: 604 year: 1987 end-page: 609 article-title: Lung cancer among Chinese women publication-title: Int J Cancer contributor: fullname: Fraumeni, JF – volume: 60 start-page: 3155 year: 2000 end-page: 3159 article-title: Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer publication-title: Cancer Res contributor: fullname: Sidransky, D – volume: 22 start-page: 673 year: 2000 end-page: 680 article-title: Role of erbB2 in breast cancer chemosensitivity publication-title: Bioessays contributor: fullname: Hung, MC – volume: 347 start-page: 472 year: 2002 end-page: 480 article-title: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors publication-title: N Engl J Med contributor: fullname: Joensuu, H – volume: 74 start-page: 1640 year: 2002 end-page: 1646 article-title: Clinical pattern and pathological stage but not histological features predict outcomes for bronchioloalveolar carcinoma (BAC) publication-title: Ann Thorac Surg contributor: fullname: Rusch, VW – volume: 61 start-page: 1309 year: 2001 end-page: 1313 article-title: Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers publication-title: Cancer Res contributor: fullname: Sidransky, D – volume: 20 start-page: 854 year: 1977 end-page: 860 article-title: Risk factors for lung cancer in Singapore Chinese, a population with high female incidence rates publication-title: Int J Cancer contributor: fullname: Shanmugaratnam, K – volume: 126 start-page: 1750 year: 2004 end-page: 1756 article-title: The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis publication-title: Chest contributor: fullname: Tan, EH – volume: 20 start-page: 23S year: 2002 end-page: 33S article-title: Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why? publication-title: J Clin Oncol contributor: fullname: Bunn, PA – volume: 304 start-page: 1497 year: 2004 end-page: 1500 article-title: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy publication-title: Science contributor: fullname: Meyerson, M – volume: 22 start-page: 785 year: 2004 end-page: 794 article-title: Gefitinib in combination with paclitaxel and carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer: results from a phase III clinical trial (INTACT 2) publication-title: J Clin Oncol contributor: fullname: Johnson, DH – volume: 35 start-page: 149 year: 1985 end-page: 155 article-title: An analysis of some risk factors for lung cancer in Hong Kong publication-title: Int J Cancer contributor: fullname: Lee, N – volume: 22 start-page: 1103 year: 2004b end-page: 1109 article-title: Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer publication-title: J Clin Oncol contributor: fullname: Heelan, RT – volume: 8 start-page: 297 year: 2001 ident: BF6602652_CR8 publication-title: Cancer Epidemiol Biomarkers Prev contributor: fullname: R Gealy – volume: 304 start-page: 1497 year: 2004 ident: BF6602652_CR21 publication-title: Science doi: 10.1126/science.1099314 contributor: fullname: JG Paez – volume: 21 start-page: 2237 year: 2003 ident: BF6602652_CR6 publication-title: J Clin Oncol doi: 10.1200/JCO.2003.10.038 contributor: fullname: M Fukuoka – volume: 22 start-page: 777 year: 2004 ident: BF6602652_CR9 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.08.001 contributor: fullname: G Giaccone – volume: 344 start-page: 783 year: 2001 ident: BF6602652_CR24 publication-title: N Engl J Med doi: 10.1056/NEJM200103153441101 contributor: fullname: DJ Slamon – volume: 61 start-page: 1309 year: 2001 ident: BF6602652_CR22 publication-title: Cancer Res contributor: fullname: M Sanchez-Cespedes – volume: 74 start-page: 1640 year: 2002 ident: BF6602652_CR5 publication-title: Ann Thorac Surg doi: 10.1016/S0003-4975(02)03897-3 contributor: fullname: MI Ebright – volume: 23 start-page: 2493 year: 2005 ident: BF6602652_CR10 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.01.388 contributor: fullname: SW Han – volume: 350 start-page: 2129 year: 2004 ident: BF6602652_CR16 publication-title: N Engl J Med doi: 10.1056/NEJMoa040938 contributor: fullname: TJ Lynch – volume: 126 start-page: 1750 year: 2004 ident: BF6602652_CR25 publication-title: Chest doi: 10.1378/chest.126.6.1750 contributor: fullname: CK Toh – volume: 22 start-page: 785 year: 2004 ident: BF6602652_CR13 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.07.215 contributor: fullname: RS Herbst – volume: 44 start-page: 1362 year: 2003 ident: BF6602652_CR2 publication-title: Proc Am Assoc Cancer Res contributor: fullname: LR Bailey – volume: 22 start-page: 1103 year: 2004 ident: BF6602652_CR19 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.08.158 contributor: fullname: VA Miller – volume: 290 start-page: 2149 year: 2003 ident: BF6602652_CR15 publication-title: JAMA doi: 10.1001/jama.290.16.2149 contributor: fullname: MG Kris – ident: BF6602652_CR20 doi: 10.1136/bmj.311.7010.899 – volume: 22 start-page: 7061 issue: no. 14S year: 2004 ident: BF6602652_CR18 publication-title: J Clin Oncol doi: 10.1200/jco.2004.22.14_suppl.7061 contributor: fullname: VA Miller – volume: 60 start-page: 3155 year: 2000 ident: BF6602652_CR1 publication-title: Cancer Res contributor: fullname: SA Ahrendt – volume: 10 start-page: 971 year: 1990 ident: BF6602652_CR11 publication-title: Anticancer Res contributor: fullname: SW Han – volume: 35 start-page: 149 year: 1985 ident: BF6602652_CR14 publication-title: Int J Cancer doi: 10.1002/ijc.2910350202 contributor: fullname: LC Koo – volume: 20 start-page: 854 year: 1977 ident: BF6602652_CR17 publication-title: Int J Cancer doi: 10.1002/ijc.2910200606 contributor: fullname: R MacLennan – volume: 40 start-page: 604 year: 1987 ident: BF6602652_CR7 publication-title: Int J Cancer doi: 10.1002/ijc.2910400505 contributor: fullname: YT Gao – volume: 15 start-page: 786 year: 2004 ident: BF6602652_CR12 publication-title: Ann Oncol doi: 10.1093/annonc/mdh177 contributor: fullname: A Haringhuizen – volume: 22 start-page: 673 year: 2000 ident: BF6602652_CR27 publication-title: Bioessays doi: 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A contributor: fullname: D Yu – volume: 18 start-page: 2095 year: 2000 ident: BF6602652_CR23 publication-title: J Clin Oncol doi: 10.1200/JCO.2000.18.10.2095 contributor: fullname: FA Shepherd – volume: 62 start-page: 4464 year: 2002 ident: BF6602652_CR26 publication-title: Cancer Res contributor: fullname: MP Wong – volume: 20 start-page: 23S issue: 18 Suppl year: 2002 ident: BF6602652_CR3 publication-title: J Clin Oncol contributor: fullname: PA Bunn Jr – volume: 347 start-page: 472 year: 2002 ident: BF6602652_CR4 publication-title: N Engl J Med doi: 10.1056/NEJMoa020461 contributor: fullname: GD Demetri |
SSID | ssj0009087 |
Score | 1.9850227 |
Snippet | We retrospectively analysed the results of patients with advanced non-small-cell lung cancer treated with gefitinib to derive clinical factors predictive of... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis springer nature |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 23 |
SubjectTerms | Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Carcinoma, Non-Small-Cell Lung - drug therapy Clinical Study Cohort Studies Drug Resistance Epidemiology Female Gefitinib Humans Logistic Models Lung cancer Lung Neoplasms - drug therapy Male Medical sciences Middle Aged Molecular Medicine Oncology Pneumology Proportional Hazards Models Quinazolines - therapeutic use Retrospective Studies Smoking Survival Analysis Tumors Tumors of the respiratory system and mediastinum |
SummonAdditionalLinks | – databaseName: Public Health Database (Proquest) dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BkRASQnwV0kLxAQkubhPHsRMuqKooFVI5Uam3yPbaItttdqm3_78z-VotVJxWiqPI6zceP4_HbwA-op3oIEPORWlmXGpT8UoXlhP4SjifBU0XnM9_qrML-eOyuBxyc-KQVjn6xM5Rz5aOYuRHAv0m7g3S9OvqD6eiUXS4OlTQeAiPMlrn6KL4ySbDo0rLXjKTonGVSEfNxrw8ivNDO3eHigowFWJrTZoUNZ-uTMRxCn2Bi_sY6L-JlH-dpnaL1OlzeDawS3bcm8MLeODbl_D4fDg_fwXX331o1k3bWNZERjm2rE_oQJ_Hmpa1Hi2bx-vlFbJCRjFa1i5bfGAWC04xfrZA58AcmcrNF-YnnWTWFS1ix3Qlkw1arfE1XJx--3VyxoeCC9whLVzzXBpbKJnKDDdRpQhWGyOqkOpgCnSozhL58FpZZAFUUt2UWe5cZoWfEbBpvgs72Cv_Fph2UhrjKqJTUlthXaBwkzJC4a-xCXwah7xe9boadXcenpd1nNcITj2Ak8Buj8j03tRwsIXQ5jsKaSNu4xLYHyGrh5kZ68mOEvgwteKUojE0rV_exloRic61TuBND-_my0VFCv7YoreAn14gse7tlrb53Yl2k8iNrLIEPo8msunT_X9877_d34cnnYosaXxm72BnfXPr3yM_WtuDbhbcAXOvD5w priority: 102 providerName: ProQuest – databaseName: SpringerOpen dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NT9wwEB0hKqFKqGppgZRCfagEF0PiOHbSG1qVIiQ4gcQtso0tsixZRJb_35kkm1UKB06RYsdy_Mae5683AL_QTnSQIeUiN3dcalPwQmeWE_hKOJ8ETRecL6_U-Y28uM1u-wOydBdmtH-f5ifN9NhO3bGiSEkZDrUf0P9qsuSJmqzEdeO808akZbdCxEtxxlffj5zPIJ25-WQabJDQRbJ4i2q-PjH537Zp643OPsOnnkay0w73L7Dm6y3YuOw3yr_C418fqkVVV5ZVDaPDtKw7uYGDG6tqVns0Yd48zh-Q_jFajGX1vMYXZjbjtJjPZjgKMEc28fyb-UEQmbXRidgp3b1kvShr8w1uzv5cT855H1mBO-R_C55KYzMlY5ngbCkXwWpjRBFiHUyGI6ezxDK8VhbdPcVON3mSOpdY4e8IwTjdhnWsld8Fpp2UxriCeJPUVlgXaF1JGaHwaWwEh8smL586AY2y3fhO87KZlghO2YMTwXaHyJBvSDgYIbQqRyE_xPlaBHtLyMq-CzalQEeLk8k4juDnkIp9h9rQ1H7-0pSK2HKqdQQ7HbyrkrOCpPoxRY-AHzKQKvc4pa7uW3VuUrORRRLB0dJEVnV6-8e_vz_rHnxstWNJ2TP5AeuL5xe_j6xoYQ_aLvEPVXUI5A priority: 102 providerName: Springer Nature |
Title | Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients |
URI | http://dx.doi.org/10.1038/sj.bjc.6602652 https://link.springer.com/article/10.1038/sj.bjc.6602652 https://www.ncbi.nlm.nih.gov/pubmed/15942627 https://www.proquest.com/docview/229989900 https://search.proquest.com/docview/68002377 https://pubmed.ncbi.nlm.nih.gov/PMC2361491 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH7ahoSQEGLAIIwVH5DgkjZxHDvhtkUbE1KnCTGpt8j2HC2lTaul-_95L7-qwk67JEocJY6_Z_uz_fw9gC9oJ6oQReTzRN_6QunUT1VsfAJfcuvCQtEG5-mVvLwRP2fxbA_ifi9M47RvTTmuFstxVd41vpXrpZ30fmKT62lGgiEiDSf7sI_dbz9E75V2g6QVyqQ5uJQHvVJjlEzq-djM7VhS2KW4iWMTp6TIrnY6pUFS8-Va11hQRRvh4jEK-r8n5T_LqU0vdfEaXnX0kp22v3EIe656A8-n3QL6W1j-cEW5KavSsLJm5GTLWo8ObPRYWbHKoWn79XL1B2kho0laVq0qvKEXC58m-dkCWwdmyVbuvzM3CCWzJmoRO6U9mawTa63fwc3F-e_s0u8iLvgWeeHGj4Q2sRSBCHEUlfDCKK15WgSq0DG2qNYQ-3BKGqQBFFNdJ2FkbWi4uyVkg-gIDjBX7gMwZYXQ2qbEp4Qy3NiC5puk5hLP2njwtS_yfN0Ka-TNgniU5PU8R5zyDicPjlpEhueGhNEOQtv3SOSNOI7z4LiHLO-qZp1z7IBxkBkEHnweUrFOURnqyq0e6lwSi46U8uB9C-_2zZ3BeKB2gB8eILXu3RQ04ka1uzNaD771JrLN0-M__vHJHzmGF43ELAmAhp_gYHP_4E6QPG3MCKvMTOExycIRPDs7v7r-hVeZzEZNNfoLpNkdSw |
link.rule.ids | 230,314,727,780,784,885,12056,12223,21388,27924,27925,31719,31720,33266,33267,33744,33745,41120,42189,43310,43579,43805,51576,53791,53793,73745,74014,74302 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED5BJwESQvwaC4PND0jw4i1xnDjhBQ20UWCtENqkvUW262jpurQs3f_PXeKmKkw8RYqjyPF3vnw-n78DeId2okpZxlxkesKl0jnPVWI4gZ8K66JS0QHn0TgdnsvvF8mFz81pfFrlyie2jnoytxQjPxToN3FtEIafFr85FY2izVVfQeM-bJFwejKArc_H45-_1qq7YdaJZlI8LhfhSrUxzg6b6YGZ2oOUSjAlYuOv1GtqPl7oBkeq7Epc3MVB_02l_Gs_tf1NnTyFJ55fsqPOIJ7BPVc_hwcjv4P-Aq6_urJaVnVlWNUwyrJlXUoHej1W1ax2aNu8uZ5fIS9kFKVl9bzGG3o24xTlZzN0D8ySsdx8ZK5XSmZt2SJ2RIcymVdrbV7C-cnx2Zch9yUXuEViuOSx1CZJZSgjXEZlojRKa5GXoSp1gi7VGqIfTqUGeQAVVddZFFsbGeEmBG0Yb8MAe-V2gCkrpdY2J0IllRHGlhRwSrVI8apNAO9XQ14sOmWNot0Rj7OimRYITuHBCWC7Q6R_rm_Y20Bo_Z4UiSMu5ALYXUFW-LnZFL0lBbDft-KkojHUtZvfNkVKNDpWKoBXHbzrNyc5afhji9oAvn-A5Lo3W-rqspXtJpkbmUcBfFiZyLpPd3_46_92fx8eDs9Gp8Xpt_GPXXjUasqS4mf0BgbLm1v3FtnS0uz5OfEHWPwUKg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED5BJ01ICPFrIxtsfkCCl6yJ48QJL2jAyvixakJM2ltku7ZI6dJu6f5_7hI3VWHiKVIcRY6_8_nz-fIdwGu0E-mES0Keq0kopCrCQqY6JPAzbmzsJP3gfDbOTi_E18v00ksKNT6tcuUTW0c9mRuKkQ85-k3cG0TR0PmsiPNPo_eL65AKSNFBq6-mcR-2cFGM-AC2PpyMz3-sFXijvBPQpNhcwaOVgmOSD5vpkZ6ao4zKMaV8Y4Xq9TUfLlSDo-a6chd38dF_0yr_Olttl6zRY3jkuSY77ozjCdyz9VPYPvOn6c_g6rN11bKqK82qhlHGLevSO9ADsqpmtUU7D5ur-W_kiIwitqye13hDzWYhRfzZDF0FM2Q4N--Y7VWTWVvCiB3TD5rMK7c2z-FidPLz42noyy-EBkniMkyE0mkmIhHjlirnTkuleOEi6VSK7tVooiJWZho5ARVYV3mcGBNrbicEc5TswAB7ZV8Ak0YIpUxB5EpIzbVxFHzKFM_wqnQAb1ZDXi46lY2yPR1P8rKZlghO6cEJYKdDpH-ubzjYQGj9ngxJJG7qAthfQVb6edqUvVUFcNi34gSjMVS1nd82ZUaUOpEygN0O3vWb04L0_LFFbgDfP0DS3ZstdfWrlfAmyRtRxAG8XZnIuk93f_jef7t_CNs4HcrvX8bf9uFBKy9L4p_xSxgsb27tKyROS33gp8QfM0sYVw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gefitinib+is+more+effective+in+never-smokers+with+non-small-cell+lung+cancer%3A+experience+among+Asian+patients&rft.jtitle=British+journal+of+cancer&rft.au=Lim%2C+S-T&rft.au=Wong%2C+E-H&rft.au=Chuah%2C+K-L&rft.au=Leong%2C+S-S&rft.date=2005-07-11&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=93&rft.issue=1&rft.spage=23&rft.epage=28&rft_id=info:doi/10.1038%2Fsj.bjc.6602652&rft_id=info%3Apmid%2F15942627&rft.externalDBID=PMC2361491 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |